Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Modern Molecular Taxonomy01:29

Modern Molecular Taxonomy

Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unveiling the Hidden Rules: Enhancing NMD Prediction for Protein-Truncating Variants.

bioRxiv : the preprint server for biology·2026
Same author

An integrated, scaled approach to resolve TSC2 variants of uncertain significance.

Nature communications·2026
Same author

Long-Term Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors.

JAMA oncology·2026
Same author

Homologous recombination deficiency-driven genomic instability in ovarian cancer as an indicator of BRCA1 and BRCA2 variant pathogenicity.

American journal of human genetics·2026
Same author

Phenotype-Specific Recalibration of MAVE Data Enables Repurposing of <i>BAP1</i> Functional Assays for Küry-Isidor Syndrome.

medRxiv : the preprint server for health sciences·2026
Same author

Not Forgotten: Patient Experiences with Genetic Variant Reclassifications.

medRxiv : the preprint server for health sciences·2026

Related Experiment Video

Updated: Jul 12, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Combining multiplexed functional data to improve variant classification.

Jeffrey D Calhoun1, Moez Dawood2,3,4, Charlie F Rowlands5

  • 1Ken and Ruth Davee Department of Neurology, Northwestern Feinberg School of Medicine, Chicago, IL, USA.

Genome Medicine
|July 10, 2026
PubMed
Summary
This summary is machine-generated.

Integrating multiplexed assays of variant effect (MAVEs) improves the classification of genetic variants. Combining data from multiple MAVE experiments provides stronger evidence for variant pathogenicity or benignity.

More Related Videos

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Published on: August 21, 2016

Related Experiment Videos

Last Updated: Jul 12, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Published on: August 21, 2016

Area of Science:

  • Genomic medicine
  • Bioinformatics
  • Clinical genetics

Background:

  • Variants of uncertain significance (VUS) pose challenges in clinical variant classification.
  • Multiplexed assays of variant effect (MAVEs) generate functional data for thousands of genetic variants.
  • Multiple MAVEs for a single gene may assess different functional impacts, necessitating data integration.

Purpose of the Study:

  • To develop and assess methods for integrating data from multiple MAVEs for improved variant classification.
  • To provide guidance on combining multiplexed functional data for clinical interpretation.
  • To evaluate the utility of integrated MAVE data in strengthening evidence for variant pathogenicity.

Main Methods:

  • Curated published MAVE datasets for TP53, LDLR, and PTEN.
  • Applied statistical and machine learning methods (PCA, k-means, Naïve Bayes, random forest) for data integration.
  • Assessed integration utility using metrics like sensitivity, specificity, and evidence strength.

Main Results:

  • Developed a stepwise process for data curation, model generation, and validation.
  • Created a web applet for testing MAVE integration methods and calculating integrated scores.
  • Supervised learning methods, particularly random forest, generally outperformed individual MAVE datasets in variant classification.

Conclusions:

  • Integrating multiple MAVE datasets strengthens functional evidence for clinical variant classification.
  • Researchers can maximize MAVE value by following structured integration processes.
  • This approach may reveal novel pathogenicity mechanisms in clinically relevant genes.